These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33126933)

  • 1. Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study.
    Kim HW; Min J; Shin AY; Koo HK; Lim SY; Park MJ; Park YB; Lee J; Lee SS; Park JS; Kim JS
    Int J Tuberc Lung Dis; 2020 Oct; 24(10):1016-1023. PubMed ID: 33126933
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
    Yu S; Sohn H; Kim HY; Kim H; Oh KH; Kim HJ; Chung H; Choi H
    PLoS Med; 2021 Jul; 18(7):e1003717. PubMed ID: 34260579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of loss to follow-up among tuberculosis patients in South Korea: whom should we focus on?
    Kim HW; Min J; Ko Y; Oh JY; Jeong YJ; Lee EH; Yang B; Koo HK; Lee SS; Park JS; Park KJ; Chang JH; Joh J; Lee MK; Kim JS
    Front Public Health; 2023; 11():1247772. PubMed ID: 37927864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea.
    Kim HW; Park S; Min J; Sun J; Shin AY; Ha JH; Park JS; Lee SS; Lipman M; Abubakar I; Stagg HR; Kim JS
    Sci Rep; 2022 Jul; 12(1):12362. PubMed ID: 35859107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of treatment failure and compliance in patients with tuberculosis.
    Koo HK; Min J; Kim HW; Lee J; Kim JS; Park JS; Lee SS
    BMC Infect Dis; 2020 Aug; 20(1):622. PubMed ID: 32831044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?
    Kawatsu L; Uchimura K; Ohkado A; Kato S
    PLoS One; 2018; 13(6):e0198075. PubMed ID: 29906287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of public and private medical facilities in tuberculosis care in Myanmar: contributions and trends over an eight-year period.
    Nwe TT; Saw S; Le Win L; Mon MM; van Griensven J; Zhou S; Chinnakali P; Shah S; Thein S; Aung ST
    Infect Dis Poverty; 2017 Sep; 6(1):123. PubMed ID: 28859677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lost to Follow-Up among Tuberculosis Patients during the Public-Private Mix Era in Rural Area of Indonesia.
    Rahayu SR; Susilastuti MS; Saefurrohim MZ; Azam M; Indrawati F; Supriyono M; Miarso D; Safitri BD; Daniswara S; Merzistya AN; Amilia R; Affandi MD; Wahidah N; Isbandi ; Wandastuti AD; Laila AK; Muflikhah Z
    Ethiop J Health Sci; 2023 Jan; 33(1):115-122. PubMed ID: 36890941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss to follow-up among patients diagnosed with spinal tuberculosis at a tertiary hospital in Western Cape Province, South Africa: A retrospective cohort study.
    Mann TN; Davis JH; Dyers R
    S Afr Med J; 2020 Mar; 110(4):284-290. PubMed ID: 32657739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes and factors affecting treatment outcomes of new patients with tuberculosis in Busan, South Korea: a retrospective study of a citywide registry, 2014-2015.
    Mok J; An D; Kim S; Lee M; Kim C; Son H
    BMC Infect Dis; 2018 Dec; 18(1):655. PubMed ID: 30545315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.
    Berry KM; Rodriguez CA; Berhanu RH; Ismail N; Mvusi L; Long L; Evans D
    BMC Public Health; 2019 Jul; 19(1):973. PubMed ID: 31331311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.
    Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC
    Cureus; 2022 May; 14(5):e25030. PubMed ID: 35591891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'They are inconveniencing us' - exploring how gaps in patient education and patient centred approaches interfere with TB treatment adherence: perspectives from patients and clinicians in the Free State Province, South Africa.
    Moodley N; Saimen A; Zakhura N; Motau D; Setswe G; Charalambous S; Chetty-Makkan CM
    BMC Public Health; 2020 Apr; 20(1):454. PubMed ID: 32252703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis Surveillance and Monitoring under the National Public-Private Mix Tuberculosis Control Project in South Korea 2016-2017.
    Min J; Kim HW; Ko Y; Oh JY; Kang JY; Lee J; Park YJ; Lee SS; Park JS; Kim JS
    Tuberc Respir Dis (Seoul); 2020 Jul; 83(3):218-227. PubMed ID: 32610836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting Mamelodi Community-Oriented Primary Care data on tuberculosis loss to follow-up through the lens of intersectionality.
    Ilunga BB; Eales OO; Marcus TS; Smith S; Hugo JF
    Afr J Prim Health Care Fam Med; 2020 Feb; 12(1):e1-e6. PubMed ID: 32129651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors leading to under-reporting of tuberculosis in the private sector in Korea.
    Hong SJ; Park YS; An H; Kang SM; Cho EH; Shin SS
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1221-7. PubMed ID: 22794136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
    Yende-Zuma N; Naidoo K
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.